Feature Channels:

Pharmaceuticals

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Myositis, necrotizing myopathy, Statin Drugs, Heart Disease, lipid-lowering medications, The Myositis Association, rare disease, autoimmune disorder

Statins Can Cause Disabling Muscle Disease

For some patients, statins cause necrotizing myopathy, a form of the rare, chronic, debilitating condition idiopathic inflammatory myopathy, also known as myositis.

Medicine

Channels:

Drug Interaction Prevention , Drug Awarness

The News About Tiger Woods Last Week Serves as a Strong Reminder That Everyone Who Takes Prescription Drugs Must Be Knowledgeable About What They're Putting Into Their Mouth

Medicine

Channels:

Anticoagulant, apixaban, Atrial Fibrillation, blood-thinner, dabigatran, Dr. Peter Noseworthy, Dr. Xiaoxi Yao, kern center, Kidney Disease, Mayo Clinic Research, Medical Research, Minnesota News Releases, news releases, OptumLabs, Overdose, Renal Disease, Research, Rivaroxaban, science of health care delivery, Stroke

1 in 6 Taking Blood-Thinning Drugs May Not Be Getting Right Dose

Almost 1 in 6 of the millions of Americans on the new blood-thinning medications for atrial fibrillation, a common heart condition characterized by an irregular and often rapid heart rate, may not be receiving the recommended dose, new Mayo Clinic research finds.

Medicine

Channels:

MD Anderson Cancer Center, Melanoma, Brain Metastases, ASCO 2017, Immunotherapy

Two Combination Therapies Shrink Melanoma Brain Metastases in More Than Half of Patients

A combination regimen of two immunotherapies and another of two targeted therapies each significantly shrank metastatic brain tumors in at least 50 percent of patients in separate multi-center clinical trials presented today at the 2017 ASCO Annual Meeting by principal investigators from The University of Texas MD Anderson Cancer Center.

Medicine

Channels:

Breast Cancer, immunotheraphy, Metastatic Cancer, pembrolizumab

Immunotherapy Drug Effective for Metastatic Triple Negative Breast Cancer

Immunotherapy trial in metastatic triple negative breast cancer patients proves to shrink tumors in patients.

Medicine

Channels:

Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering, ASCO, ASCO 2017, #ASCO17, david hyman, loxo oncology, Precision Medicine, Pediatrics

Results Indicate That Larotrectinib Is Effective as the First Novel Targeted Therapy to Show a Consistent Response across Multiple Tumor Types in Adult and Pediatric Patients

Larotrectinib (LOXO-101) has demonstrated consistent and durable antitumor activity in tropomyosin receptor kinase (TRK) fusion cancers across a wide range of patient ages and tumor types and was well tolerated by patients, according to results from three clinical trials presented today at the annual meeting of the American Society of Clinical Oncology in Chicago. David Hyman, MD, Chief of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center (MSK) and global principal investigator of the NAVIGATE trial testing larotrectinib, shared the landmark data from three multisite clinical trials in a press conference at the meeting.

Medicine

Science

Channels:

World War Ii, Penicillin, Bacteriology, Biochemistry, Military, History, Health, Drugs

D-Day Invasion Was Bolstered by UW–Madison Penicillin Project

StaufferandBackus.jpg

Seventy-three years ago Tuesday, on June 6, 1944, the D-Day invasion of Normandy was bolstered by millions of doses of a precious new substance: penicillin. On the other side of the Atlantic, researchers at the University of Wisconsin–Madison and other institutions had spent the last three years pursuing advances in penicillin production.

Medicine

Science

Channels:

Science, Research, NMR spectroscopy, craft, Magnetic Resonance, Chemistry, medical advances

Faculty-Student Research Team Uncovers Critical Process in Drug Development

ScreenShot2017-06-01at3.07.05PM.png

A faculty-student research team in the chemistry lab at the University of Redlands has advanced a new approach to a critical process in pharmaceutical drug development that could reduce the time and cost of bringing a drug from concept to market.

Medicine

Channels:

Payments Linked to Higher Odds of Doctors Prescribing Certain Cancer Drugs

Mitchell.jpg

In preliminary findings (abstract 6510) that will be presented at the American Society of Clinical Oncology Annual Meeting 2017 in Chicago on Saturday, June 3, researchers show that when physicians had to choose between multiple, on-patent drugs for metastatic kidney cancer and chronic myeloid leukemia, they were more likely to prescribe drugs from companies they had received general payments from.

Medicine

Channels:

Propofol, Anesthesia, Kinesins, motor proteins, Mechanism, Susan Gilbert, Roderic G. Eckenhoff, Rensselaer Polytechnic Institute, , University Of Pennsylvania

Research Uncovers a Novel Mechanism of Common Anesthetic Propofol

S.GilbertPropofol.jpg

Research published in the Proceedings of the National Academy of Science, and supported by the National Institutes of Health, identifies a previously unknown mechanism of the anesthetic propofol that may help to explain its outcomes, knowledge that could lead to safer anesthetics.







Chat now!